TY  - GEN
AU  - Ghesquières,Hervé
AU  - Cartron,Guillaume
AU  - Seymour,John Francis
AU  - Delfau-Larue,Marie-Hélène
AU  - Offner,Fritz
AU  - Soubeyran,Pierre
AU  - Perrot,Aurore
AU  - Brice,Pauline
AU  - Bouabdallah,Réda
AU  - Sonet,Anne
AU  - Dupuis,Jehan
AU  - Casasnovas,Olivier
AU  - Catalano,John Vincent
AU  - Delmer,Alain
AU  - Jardin,Fabrice
AU  - Verney,Aurélie
AU  - Dartigues,Peggy
AU  - Salles,Gilles
TI  - Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms
SN  - 1528-0020
PY  - 2013///0110
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - therapeutic use
KW  - Antineoplastic Agents
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - International Agencies
KW  - Lymphoma, Follicular
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Polymorphism, Single Nucleotide
KW  - genetics
KW  - Prognosis
KW  - Prospective Studies
KW  - Receptors, IgG
KW  - Remission Induction
KW  - Rituximab
KW  - Survival Rate
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2012-05-431825
ER  -